Heeyo.ai, a pioneering company dedicated to revolutionizing children's education through artificial intelligence, has successfully raised $3.5 million in its latest funding round. This significant investment will propel the development of their innovative platform, which connects kids with smart AI friends designed to enhance learning experiences. Since its inception, Heeyo.ai has garnered recognition for its engaging approach, combining cutting-edge technology with interactive learning to captivate young minds. The funds will be allocated towards expanding their educational content library, improving the AI's personalized learning algorithms, and enhancing user experience on their app, which is readily available on both iOS and Android. With a focus on building foundational skills in a fun and interactive manner, Heeyo.ai aims to empower children to explore subjects ranging from math and science to art and languages. The company's mission is rooted in the belief that learning should be enjoyable and accessible to all children, fostering a sense of curiosity that lasts a lifetime. As Heeyo.ai embarks on this exciting phase of growth, the company firmly positions itself at the forefront of the edtech sector, ensuring that kids everywhere can benefit from high-quality, engaging, and personalized educational experiences through their AI companions. Stay tuned for their upcoming features and enhancements that promise to make learning even more fun and effective!

Heeyo.ai Secures $3.5 Million in Seed Funding for Innovative Smart AI Learning Companion for Kids
Get the full Heeyo.ai company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all.png&w=3840&q=75)
ChAbS (Chinese Antibody Society)
The ChAbS(华人抗体协会) is an independent non-profit, non-government global professional organization with focus upon antibody-based therapeutics. The mission of the society is to bring together industry, academics, healthcare providers, and investors to connect, communicate, and collaborate on the discovery, development, manufacturing, and marketing of therapeutic antibodies. Through its programs and services, the society serves as a nurturing platform to foster the productive interaction and networking among its members worldwide. The society, in collaboration with Oxford University Press, publishes its official journal, Antibody Therapeutics which is indexed by ESCI (IF: 4.5), PubMed and Scopus (CiteScore: 8.5).
$101.0M Series b
today

Pogo
Pogo is the world’s first AI video interviewing platform powered by purchase-verified respondents. In under an hour, brands can find and conduct video interviews with thousands of their actual buyers – all through the Pogo app, where three million users share their complete purchase history, capturing 1 in 150 U.S. shopping trips down to the SKU.
$32.0M Unknown
today

F2
F2 is the compounding intelligence platform for private markets. Purpose-built for private credit and commercial banking, F2 powers how investment teams screen, diligence, underwrite, and monitor deals — turning every transaction into a proprietary advantage that makes the firm smarter over time. At the core is Institutional Knowledge: F2 ingests your firm's IC memos, models, CIMs, and CRM data into a living, queryable library of past judgment. Teams pull precedents in minutes, surface how the firm previously evaluated a sector or sponsor, and underwrite with the pattern recognition of their most experienced MD — and every new deal flows back in automatically, so the library compounds. Unlike general-purpose AI, F2 is Excel-native, running a real Excel engine under the hood with live formulas, dependency tracking, and Audit Mode that traces every number back to its source. F2 ranks #1 on SpreadsheetBench, the industry standard for spreadsheet AI. SOC 2 Type 1 & Type 2 certified and GDPR compliant, with zero data retention and no model training on customer data. Today, more than 15,000 deals are underwritten on F2 annually across firms managing over $400B in client assets. Headquartered in New York City, F2 is backed by leading investors including NFX, Left Lane Capital, and Y Combinator.
$14.0M Seed
today

EqualAI
EqualAI is a nonprofit organization that helps companies, policy makers, and leading institutions define and implement AI governance in support of innovation and broader AI adoption. By partnering with thought and industry leaders, EqualAI fosters AI practices that promote adoption and greater societal benefit.
$30.0M Series b
today

Protein Industries Canada
Protein Industries Canada is an industry-led value chain consortium of small- to large-sized enterprises involved in food and food ingredient manufacturing, agriculture and food-related services, research and development, technology, economic development, finance and investment, education and training. Protein Industries Canada is a not-for-profit corporation guided by a board comprising industry leaders.
$10.5M Series a
today
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() F2 | Seed | $14.0M | today |
| 2 | ![]() Skillmaker.AI United States | Seed | $4.5M | today |
| 3 | ![]() Western CAM United States | Seed | $2.2M | today |
| 4 | ![]() Agenz Morocco | Seed | $5.0M | today |
| 5 | ![]() Relai Switzerland | Seed | $5.4M | today |



